Politics FDA to fast-track review of application to allow NARCAN to be sold over the counter Washington Examiner · December 7, 2022 1:29 pm
Healthcare Anticipation and skepticism surround Alzheimer’s drug on fast track for approval Abigail Adcox · November 28, 2022 9:00 pm
Healthcare FDA approves first drug to delay onset of Type 1 diabetes Misty Severi · November 18, 2022 9:46 pm
News Adderall shortage fueled by sharp rise in ADHD diagnoses Abigail Adcox · November 15, 2022 4:29 pm
News Experimental Alzheimer’s drug fails to slow cognitive decline in clinical trials Abigail Adcox · November 14, 2022 4:36 pm
News Nearly 90% of community pharmacies report issues stocking Adderall Abigail Adcox · November 3, 2022 7:01 pm
News CVS, Walgreens, and Walmart agree to pay $12 billion to settle opioid lawsuits Abigail Adcox · November 2, 2022 3:08 pm
Healthcare NIH to use Pfizer’s Paxlovid to study causes of long COVID Abigail Adcox · October 28, 2022 8:39 pm
News FDA indefinitely delays meeting to review first over-the-counter birth control Abigail Adcox · October 26, 2022 9:28 pm
Healthcare Pfizer to charge $130 for COVID-19 vaccination once government stops making them free: Report Ryan King · October 22, 2022 7:59 pm
Politics
